On July 30, several brokerages released their views on key Indian stocks. Most updates reflected a positive outlook, especially on Larsen & Toubro (L&T), Asian Paints, and a few other names. Here’s a summary of the major calls:
Larsen & Toubro (L&T)
Brokerages remain largely positive on L&T.
-
Jefferies: Buy, target raised to ₹4,230 from ₹3,965
-
B&K: Buy, target raised to ₹4,034 from ₹3,986
-
Haitong: Outperform, target raised to ₹4,150 from ₹3,800
-
Investec: Buy, target raised to ₹4,460 from ₹4,115
-
Motilal Oswal: Buy, target raised to ₹4,200 from ₹4,100
-
Axis: Buy, target ₹4,270
-
Emkay: Buy, target ₹4,000
Asian Paints
Views are mixed on Asian Paints, with some raising targets and others turning cautious.
-
JP Morgan: Upgraded to Neutral, target ₹2,500
-
Jefferies: Buy, target raised to ₹2,900
-
Macquarie: Outperform, target ₹2,700
-
Goldman Sachs: Buy, target raised to ₹2,250
-
HSBC: Buy, target cut to ₹2,800
-
Investec: Buy, target ₹2,050
-
CLSA: Reduce, target ₹1,926
-
Morgan Stanley: Underweight, target ₹1,909
Piramal Enterprises (PEL)
-
CLSA: Neutral, target raised to ₹1,200
-
Motilal Oswal: Buy, target raised to ₹1,315
InterGlobe Aviation (IGI)
-
Morgan Stanley: Overweight, target ₹533
Adani Green
-
Jefferies: Buy, target ₹1,300
Ather Energy
-
HSBC: Initiated with Buy, target ₹450
-
Nomura: Initiated with Buy, target ₹458
NTPC
-
Nuvama: Buy, target raised to ₹401
Apar Industries
-
Nuvama: Buy, target raised to ₹12,100
Nippon AMC
-
Nomura: Buy, target raised to ₹880
-
HSBC: Buy, target raised to ₹690
Metal Stocks (Tata Steel, Jindal Stainless)
-
Jefferies lists them as top picks amid improving spreads and 8–10% volume growth outlook over FY25–27
Varun Beverages (VBL)
-
CLSA: Outperform, target ₹774
-
Nuvama: Buy, target cut to ₹606
-
Jefferies: Buy, target ₹600
Piramal Pharma
-
Motilal Oswal: Buy, target ₹240
GAIL
-
Motilal Oswal: Buy, target ₹210
-
Macquarie: Outperform, target ₹215
Bank of India
-
Morgan Stanley: Underweight, target ₹110
Tata Motors
-
UBS: Sell, target ₹690
Disclaimer: The brokerage views expressed above are solely those of the respective firms. They do not represent the opinion of this publication and should not be construed as investment advice. Please consult your financial advisor before making any investment decisions.
